PTC is a science-driven, patient-centered biopharmaceutical company focused on discovering, developing & commercializing medicine for patients with rare disease.



Biotechnology

Health Care

Pharmaceutical

PTC Therapeutics

PTC Therapeutics' headquarters in South Plainfield, NJ, United States

Matthew B. Klein

Eddy Tufford

Pierre Gravier

Yasutsugu Iino

Gabriel Holdsman

Daphny M.

Jeff Trimmer

John Baird

Lee Golden

Eric Pauwels

Mary Frances Harmon

Neil Almstead

Stephanie Okey

Glenn D. Steele Jr.

Emma Reeve

Michael Schmertzler

Mary Smith

Alethia Young

Stephanie S. Okey

Allan Jacobson

David P. Southwell

Jerome B. Zeldis

The Leadership Team at PTC Therapeutics is responsible for guiding the strategic direction of the company, ensuring alignment between scientific innovation and patient needs. This diverse group of executives collaborates across functions, including legal, regulatory, operations, and finance, to foster a culture of compliance and quality while driving research and commercial initiatives in the biopharmaceutical sector. Their collective expertise enables PTC to effectively address the challenges of developing therapies for rare diseases, ultimately aiming to improve patient outcomes and broaden access to essential medicines.

Leadership Team

The Research and Development team at PTC Therapeutics is dedicated to advancing innovative therapies for rare diseases through rigorous scientific research and collaboration. This multidisciplinary team encompasses expertise in areas such as informatics, pharmacology, and chemistry, focusing on early discovery and the development of drug candidates. Their efforts include conducting high-throughput screening, biomarker identification, and analytical project management to drive the company's pipeline and improve patient outcomes.

Research and Development

The Global Marketing and Communications team at PTC Therapeutics is responsible for developing and implementing strategic marketing initiatives that effectively promote the company’s innovative therapies for rare diseases. This diverse team collaborates on brand messaging, digital communications, and corporate outreach, ensuring alignment across regions, including DACH, the UK, Ireland, and Japan. Their efforts aim to enhance awareness, engage key stakeholders, and ultimately support the patient-centered mission of bringing life-changing medicines to those in need.

Global Marketing and Communications

The Regulatory Affairs and Quality Assurance team at PTC Therapeutics ensures that the company complies with all regulatory requirements throughout the drug development process. They oversee quality assurance for Good Manufacturing Practices (GMP) and Good Clinical Practices (GXP), manage pharmacovigilance and risk assessment, and lead the strategic development of regulatory submissions. This team plays a crucial role in safeguarding patient safety while facilitating the successful commercialization of innovative therapies for rare diseases.

Regulatory Affairs and Quality Assurance

The Data Analytics and Business Intelligence team at PTC Therapeutics leverages advanced analytics and statistical programming to derive actionable insights from complex healthcare data. This team collaborates across departments to support strategic decision-making, optimize forecasting processes, and enhance the efficiency of drug development and commercialization strategies for rare diseases, ultimately aiming to improve patient outcomes.

Data Analytics and Business Intelligence

The Clinical Operations team at PTC Therapeutics is responsible for the planning, execution, and management of clinical trials to ensure the safety and efficacy of innovative therapies for rare diseases. This team collaborates closely with cross-functional partners to streamline clinical processes, maintain compliance with regulatory standards, and deliver high-quality data that drives the development of patient-centered biopharmaceutical solutions.

Clinical Operations

PTC Therapeutics

Org chart

Board & advisors

Teams